N. Galldiks

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
N Galldiks, N. Galldiks, Norbert Galldiks
Publication record
345 papers · 11,984 citations · H-index 54

PAPERS

Assessment of Response to Regorafenib in Patients with Glioma Relapse Using 18F-FET PET and MRI
20260 citationsauthor #13
Influence of oral protein intake on [18F]FET uptake in brain tumours
20250 citationsauthor #2
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma
20250 citationsauthor #11
An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
20251 citationsauthor #12
Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PET
20251 citationsauthor #13
Borderline Findings in O-(2-[18F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
20251 citationsauthor #20
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
20253 citationsauthor #3
Brain Tumor Characterization Using Multiple MR Parameters From Multi‐Contrast EPI With Keyhole (GE‐SE EPIK) Including Oxygen Extraction Fraction: A Comparison to O‐(2‐[18F]Fluoroethyl)‐L‐Tyrosine (FET) Positron Emission Tomography
20250 citationsauthor #6
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
20252 citationsauthor #25
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0
20258 citationsauthor #6
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
202442 citationsauthor #22
PET imaging of gliomas: Status quo and quo vadis?
202418 citationsauthor #1
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
202482 citationsauthor #2
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.
202412 citationsauthor #3
Example of Artificial Intelligence–Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management
20240 citationsauthor #6
Challenges, Limitations and Pitfalls of PET and Advanced MRI in Patients with Brain Tumors - A Report of the PET/RANO Group.
202442 citationsauthor #1
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements.
202415 citationsauthor #26
Radiomics workflow definition & challenges - German priority program 2177 consensus statement on clinically applied radiomics
20247 citationsauthor #17
MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis
20245 citationsauthor #11
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
20230 citationsauthor #19
NCOG-04. WHOLE-BRAIN STRUCTURAL CONNECTIVITY PREDICTS COGNITIVE DEFICITS IN PRETREATED PATIENTS WITH CNS WHO GRADE 3 OR 4 GLIOMAS
20230 citationsauthor #12
Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET.
20230 citationsauthor #10
Structural connectome-based predictive modeling of cognitive deficits in treated glioma patients.
202310 citationsauthor #12
Advances in PET imaging for meningioma patients
202320 citationsauthor #1
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
20232 citationsauthor #4
NIMG-20. ASSESSMENT OF RESPONSE TO REGORAFENIB IN RECURRENT GLIOMA PATIENTS USING FET PET AND MRI INCLUDING ADC VALUES
20230 citationsauthor #10
NIMG-05. CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF BRAIN METASTASES AFTER TREATMENT WITH STEREOTACTIC RADIOSURGERY USING SERIAL FET PET IMAGING
20230 citationsauthor #12
The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis
20233 citationsauthor #11
Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors
20230 citationsauthor #2
Amino Acid PET in Neurooncology
202344 citationsauthor #1
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.
20235 citationsauthor #14
Clinical Applications of Radiomics in Nuclear Medicine
20231 citationsauthor #6
Imaging Characteristics of Meningiomas.
20230 citationsauthor #1
Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI
20234 citationsauthor #9
Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial
20230 citationsauthor #2
Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
202310 citationsauthor #14
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
202328 citationsauthor #6
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer
202315 citationsauthor #3
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
202215 citationsauthor #14
Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
202217 citationsauthor #3
NIMG-27. THE PROGNOSTIC VALUE OF FET PET IN PATIENTS WITH RECURRENT GLIOMA TREATED WITH BEVACIZUMAB
20220 citationsauthor #12
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: a joint EORTC BTG and RANO effort.
202215 citationsauthor #13
AI-based decision support improves reproducibility of tumor response assessment in neuro-oncology: an international multi-reader study.
202242 citationsauthor #4
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
202219 citationsauthor #12
NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL
20220 citationsauthor #18
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
202215 citationsauthor #8
An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET
20222 citationsauthor #1
Radiomics in neuro-oncological clinical trials.
202254 citationsauthor #8
Use of advanced neuroimaging and artificial intelligence in meningiomas
202216 citationsauthor #1
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
202226 citationsauthor #12
Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
202216 citationsauthor #18
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
202227 citationsauthor #6
Imaging patterns in patients with newly diagnosed glioblastoma in England.
20220 citationsauthor #1
The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomas.
20225 citationsauthor #1
Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease
20221 citationsauthor #11
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas
202213 citationsauthor #12
CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT
20220 citationsauthor #23
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.
202224 citationsauthor #1
Correction to: Repeated amino acid PET imaging for longitudinal monitoring of brain tumors
20223 citationsauthor #2
Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases.
202125 citationsauthor #5
Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
20214 citationsauthor #12
Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
202124 citationsauthor #8
Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
20217 citationsauthor #4
Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.
20210 citationsauthor #1
Radiomics for the non-invasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
20213 citationsauthor #3
P14.41 Cost-effectiveness of FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy
20210 citationsauthor #8
NIMG-04. PREDICTING THE BRAF MUTATIONAL STATUS IN PATIENTS WITH MELANOMA BRAIN METASTASES USING RADIOMICS - A BICENTRIC STUDY
20210 citationsauthor #3
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.
2021440 citationsauthor #7
18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection
202124 citationsauthor #7
Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
20210 citationsauthor #5
A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs
20213 citationsauthor #9
NIMG-06. CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF IRRADIATED BRAIN METASTASES USING SERIAL DYNAMIC FET PET IMAGING
20211 citationsauthor #1
P14.79 Differentiation of treatment-related changes from tumor progression following brachytherapy in patients with WHO II and III gliomas using FET PET
20210 citationsauthor #10
Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
202127 citationsauthor #18
Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis?
20210 citationsauthor #1
NIMG-20. DIFFERENTIATION OF TREATMENT-RELATED CHANGES FROM TUMOR PROGRESSION FOLLOWING BRACHYTHERAPY IN PATIENTS WITH WHO II AND III GLIOMAS USING FET PET
20211 citationsauthor #10
OS03.3.A Characterization of long-term metabolic changes of irradiated brain metastases using serial dynamic FET PET imaging
20211 citationsauthor #1
Use of PET Imaging in Neuro-Oncological Surgery
202128 citationsauthor #3
Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CT.
20217 citationsauthor #7
Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
20219 citationsauthor #12
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
202110 citationsauthor #12
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.
202196 citationsauthor #1
NIMG-38. NON-INVASIVE PREDICTION OF MGMT PROMOTER METHYLATION USING COMBINED FET PET/MRI RADIOMICS
20200 citationsauthor #10
FET PET radiomics for the diagnosis of pseudoprogression in patients with glioblastoma
20200 citationsauthor #10
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
202048 citationsauthor #6
NIMG-26. DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET
20200 citationsauthor #16
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
202034 citationsauthor #5
NIMG-14. MACHINE LEARNING-BASED EVALUATION OF STATIC AND DYNAMIC FET-PET FOR THE DETECTION OF PSEUDOPROGRESSION IN PATIENTS WITH IDH-WILDTYPE GLIOBLASTOMA
20200 citationsauthor #5
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
202012 citationsauthor #5
NIMG-43. IMAGING FINDINGS FOLLOWING REGORAFENIB IN PATIENTS WITH MALIGNANT GLIOMA: FET PET ADDS VALUABLE INFORMATION TO ANATOMICAL MRI
20200 citationsauthor #7
32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
20201 citationsauthor #1
Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment
202026 citationsauthor #13
Feature-based PET/MRI radiomics in patients with brain tumors
202022 citationsauthor #9
Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
202010 citationsauthor #1
MRI Follow‐up of Astrocytoma: Automated Coregistration and Color‐Coding of FLAIR Sequences Improves Diagnostic Accuracy With Comparable Reading Time
20203 citationsauthor #11
Radiomics in Neuro-Oncology: Basics, Workflow, and Applications.
2020113 citationsauthor #2
PET/MRI Radiomics in Patients With Brain Metastases
202081 citationsauthor #8
18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
202063 citationsauthor #7
Effect of Zolpidem in the Aftermath of Traumatic Brain Injury: An MEG Study
202018 citationsauthor #8
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
202033 citationsauthor #5

TIMELINE

2003 63 citations

2004 728 citations

2005 268 citations

2006 504 citations

2007 90 citations

2008 41 citations

2009 86 citations

2010 105 citations

2011 252 citations

2012 744 citations

2013 625 citations

2014 214 citations

2015 1,193 citations

2016 1,248 citations

2017 1,148 citations

2018 1,327 citations

2019 1,092 citations

2020 814 citations

2021 710 citations

2022 310 citations

2023 142 citations

2024 223 citations

2025 16 citations

2026 0 citations

N. Galldiks

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT